Uniform sarcolemmal dystrophin expression is required to prevent extracellular microRNA release and improve dystrophic pathology. (2020)
Attributed to:
Antisense Oligonucleotide Therapy for Neuromuscular Disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/jcsm.12506
PubMed Identifier: 31849191
Publication URI: http://europepmc.org/abstract/MED/31849191
Type: Journal Article/Review
Volume: 11
Parent Publication: Journal of cachexia, sarcopenia and muscle
Issue: 2
ISSN: 2190-5991